grant
Administrative Core
Organization MAYO CLINIC ROCHESTERLocation ROCHESTER, UNITED STATESPosted 15 Sept 2019Deadline 31 Aug 2030
NIHUS FederalResearch GrantFY2025AD dementiaAD related dementiaADRDAddressAffectAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimer's and related dementiasAlzheimer's dementia and related dementiaAlzheimer's dementia or related dementiaAlzheimer's disease and related dementiaAlzheimer's disease and related disordersAlzheimer's disease or a related dementiaAlzheimer's disease or a related disorderAlzheimer's disease or related dementiaAlzheimer's disease related dementiaAlzheimers DementiaAutopsyBlood PlasmaCaregiver instructionCaringClinicalClinical ResearchClinical StudyClinical TrialsClinical Trials DesignClinical assessmentsCollaborationsCollectionCommunicationCommunitiesComplexDNADataData Management and Analysis CoreData Management and Statistical Analysis CoreData Management and Statistical CoreData SetDeoxyribonucleic AcidDevelopmentDiseaseDisorderEducationEducational aspectsEnrollmentEnsureEvaluationFDA approvedFTD dementiaFTLDFaceFamilyFosteringFrontal Temporal DementiaFrontal Temporal Lobar DegenerationFrontotemporal DementiaFrontotemporal Lobar DegenerationsFrontotemporal variety lobar degenerationFundingGeneticHealth Care TechnologyHealth TechnologyImageIndividualInfrastructureInterventionInvestigatorsKnowledgeLaboratoriesMRI ScansMagnetic Resonance Imaging ScanMeasuresNational Institute of AgingNational Institute on AgingNational Institutes of HealthNerve DegenerationNeuron DegenerationNeuropsychologiesNeuropsychologyNorth AmericaPBMCParticipantPeripheral Blood Mononuclear CellPersonnel ManagementPersonsPhasePlasmaPlasma SerumPrimary Senile Degenerative DementiaProceduresProcessProductivityProtocolProtocol ComplianceProtocols documentationR-Series Research ProjectsR01 MechanismR01 ProgramRecommendationRegistriesResearchResearch GrantsResearch PersonnelResearch PriorityResearch Project GrantsResearch ProjectsResearch ResourcesResearchersResourcesReticuloendothelial System, Serum, PlasmaSamplingScanningSecureServicesSpeedStandardizationStructureSymptomsSyndromeTechnology AssessmentUnited States National Institutes of Healthadvanced directivecare giver educationcare giver instructioncare giver trainingcareercaregiver educationcaregiver trainingclinical research siteclinical sitecommunity engaged participatory researchcommunity engaged researchcommunity partnered researchcommunity partnerscommunity-based partnerscommunity-engaged studycommunity-partnered studyconferenceconventiondata infrastructuredata sharingdata storage sitedepositorydesigndesigningdevelopmentaldigital healtheffective therapyeffective treatmentenrollfacesfacialfront temporal dementiafrontal lobe dementiafrontotemporal lobar degeneration dementiafrontotemporal lobar dementiafrontotemporal lobe degeneration associated with dementiaimagingindustrial partnershipindustry partnerindustry partnershipkindredmembernecropsyneural degenerationneural imagingneuro-imagingneurodegenerationneurodegenerativeneuroimagingneurological degenerationneurological imagingneuronal degenerationneuropsychologicnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyoutreachpatient advocacy groupphenotypic datapostmortempre-clinicalpreclinicalpreventpreventingprimary degenerative dementiaprogramsrecruitremote assessmentremote evaluationrepositorysenile dementia of the Alzheimer typesummitsymposiasymposiumtreatment trialtrial planning
Description preview
Frontotemporal lobar degeneration (FTLD) represents the group of neurodegenerative proteinopathies that manifest as a spectrum of complex clinical syndromes. There are no FDA-approved interventions that positively affect symptoms, slow the rate of progression, or delay or prevent the development of symptoms for those who may develop FTLD. The…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click